EASTON, MA and NEW YORK, NY / ACCESSWIRE / March 10, 2015 / Pressure BioSciences Inc., (« PBI » or the
« Company ») (PBIO), a company focused on the development, marketing, and
sale of proprietary laboratory instrumentation and associated consumables based
on Pressure Cycling Technology (« PCT »), granted an exclusive interview at the
recent FSXinterlinked Investment Conference, held in New Orleans.
Pressure BioSciences Inc.,
(« PBI ») (PBIO) was one of the presenting companies at the
recent FSXinterlinked Investment Conference, held at the Ritz Carlton, New
Orleans.
PBI is focused on the
development, marketing, and sale of proprietary laboratory instrumentation and
associated consumables based on Pressure Cycling Technology (« PCT »). PCT is a patented, enabling technology
platform with multiple applications in the estimated $6 billion life sciences
sample preparation market. PCT uses cycles of hydrostatic pressure between
ambient and ultra-high levels to precisely and reproducibly control
bio-molecular interactions.
During the event,
FSXinterlinked host, Troy Vanderburg, interviewed Richard T. Schumacher, PBI’s
CEO.
« Troy possesses a unique
industry perspective, developed through many years of capital markets
experience, which enables him to ask just the right questions to get the most
informative descriptions of what these companies do and who these entrepreneurs
really are. » stated Delray Wannemacher, FSXinterlinked President.
During the interview, Mr.
Schumacher shared exciting news about the Company. Mr. Schumacher stated, « We
think this is our year. We believe this
is the year we cross over that threshold from being a research-based company to
being a marketing and sales driven company. We have started to hire the team needed to move forward, we have already
developed the unique PCT-based product line, and we believe our financial
situation is better than it has been in some time. We have also started to talk in earnest with
several potential strategic partners. You put all that together and we think we
are going to have one great year. »
The complete exclusive interview is available only on the FSXinterlinked channel on
InterlinkedTV.
More information is available
at PBIO’s Public Profile on Interlinked.com and on their website.
About FSXinterlinked
Investment Conference
FSXinterlinked is the premier
investment conference organization in the United States. Founded as Financial
Services Exchange (FSX) in 1983, it is one of the longest standing and most
trusted investment conferences in the country for Broker Dealers and financial
professionals. For more information about our organization please visit
FSXinterlinked.com.
About Interlinked
Interlinked is a global
investment community of investors, emerging growth companies, and resource
partners. Interlinked offers an efficient way for companies to maximize
exposure and access a private network of funding sources and verified service
providers. For investors, Interlinked provides a secure environment to find,
vet and engage companies, and communicate with members. Interlinked gives
members exclusive access to a proprietary investment platform, which integrates
virtual data rooms, video news, a service provider marketplace, an event
directory, and customized marketing services, including email marketing, video
production, public relations and more. For more information, visit:
http://www.interlinked.com/.
Safe Harbor Statement
This press release may contain
information that constitutes forward-looking statements made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
All statements, trends, analysis, and other information contained in this press
release, including words such as « anticipate, » « believe, »
« plan, » « estimate, » « expect, » « intend, »
and other similar expressions of opinion, constitute forward-looking
statements. Any such forward-looking statements involve risks and uncertainties
that could cause actual results to differ materially from any future results
described within the forward-looking statements. Risk factors that could
contribute to such differences include those matters more fully disclosed in
the Company’s reports filed with the Securities and Exchange Commission. The
forward-looking information provided herein represents the Company’s estimates
as of the date of the press release, and subsequent events and developments may
cause the Company’s estimates to change. The Company specifically disclaims any
obligation to update the forward-looking information in the future. Therefore,
this forward-looking information should not be relied upon as representing the
Company’s estimates of its future financial performance as of any date
subsequent to the date of this press release.
SOURCE: Pressure Biosciences, Inc.
- Finance
- Investment Company Information